Hosted on MSN15d
Mass.-based Moderna could be first to manufacture bird flu vaccine
A Moderna spokesperson told MassLive the company is preparing to advance its bird flu vaccine (mRNA-1018) into a phase 3 study, “based on the positive preliminary data from the Phase 1/2 study ...
Falling vaccination rates in Trump’s America hit Australian giant
The Melbourne-based company on Tuesday posted what chief executive Paul McKenzie described as a robust set of half-year ...